Potassium channel blockers in multiple sclerosis: Neuronal Kv channels and effects of symptomatic treatment
- 1 July 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 111 (1) , 224-259
- https://doi.org/10.1016/j.pharmthera.2005.10.006
Abstract
No abstract availableKeywords
This publication has 342 references indexed in Scilit:
- Axonal excitability revisitedProgress in Biophysics and Molecular Biology, 2005
- Acute demyelination disrupts the molecular organization of peripheral nervous system nodesJournal of Comparative Neurology, 2004
- KV1.1 K+ Channels Identification in Human Breast Carcinoma Cells: Involvement in Cell ProliferationBiochemical and Biophysical Research Communications, 2000
- Energetic and structural interactions between δ-dendrotoxin and a voltage-gated potassium channel 1 1Edited by G. von HeijneJournal of Molecular Biology, 2000
- An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantulaNeuron, 1995
- The charybdotoxin family of K+ channel-blocking peptidesNeuron, 1995
- The charybdotoxin receptor of a Shaker K+ channel: Peptide and channel residues mediating molecular recognitionNeuron, 1994
- Segmental exchanges define 4-aminopyridine binding and the inner mouth of K+ poresNeuron, 1993
- Shaker, Shal, Shab, and Shaw express independent K+ current systemsNeuron, 1991
- Mapping the receptor site for charybdotoxin, a pore-blocking potassium channel inhibitorNeuron, 1990